Human Trials Of Vaccine Candidate Should Start in 10 Days: Company Official

  • 7:33
  • Published On: July 01, 2020
Cinema View
Embed

Bharat Biotech has developed COVAXIN, India's 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research, National Institute of Virology. In an interview to NDTV, Dr Krishna Ella, Chairman and MD of Bharat Biotech, said that most of the clearances are coming through and in 10 days human trials should start.

Advertisement

Related Videos

"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
August 22, 2023 1:33
World's 1st Covid Nasal Vaccine Out On Republic Day
January 26, 2023 8:39
India Gets Its Own Nasal Vaccine, Booster Costs Rs. 800 Per Dose
January 26, 2023 1:18
"Isolated Events Can't Dent India's Image": Adar Poonawalla To NDTV
January 17, 2023 2:05
"We Are Trying To Engage With China": Adar Poonawalla To NDTV
January 17, 2023 1:27
Adar Poonawalla On Top 3 Developments In Vaccine World
January 17, 2023 0:48
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
January 17, 2023 13:53
Serum Institute Offers Free Vaccine Doses to Centre, Other Top Stories
December 29, 2022 53:57
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
December 29, 2022 1:27
"Have No Stock": Government Hospital In Delhi Halts Covid Vaccinations
December 28, 2022 2:53
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
December 28, 2022 2:33
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination